16 articles for T Muto
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Orally active ghrelin receptor inverse agonists and their actions on a rat obesity model.
Asubio Pharma
2-Aminoalkyl nicotinamide derivatives as pure inverse agonists of the ghrelin receptor.
Asubio Pharma
Discovery of novel series of 6-benzyl substituted 4-aminocarbonyl-1,4-diazepane-2,5-diones as human chymase inhibitors using structure-based drug design.
Asubio Pharma
1,2,3-Triazole-containing uracil derivatives with excellent pharmacokinetics as a novel class of potent human deoxyuridine triphosphatase inhibitors.
Taiho Pharmaceutical
Discovery of highly potent human deoxyuridine triphosphatase inhibitors based on the conformation restriction strategy.
Taiho Pharmaceutical
Discovery of a novel class of potent human deoxyuridine triphosphatase inhibitors remarkably enhancing the antitumor activity of thymidylate synthase inhibitors.
Taiho Pharmaceutical
Development of 6-benzyl substituted 4-aminocarbonyl-1,4-diazepane-2,5-diones as orally active human chymase inhibitors.
Daiichi Asubio Pharma
Identification of 6-substituted 4-arylsulfonyl-1,4-diazepane-2,5-diones as a novel scaffold for human chymase inhibitors.
Daiichi Asubio Pharma
Discovery and structure-activity relationships of spiroindolines as novel inducers of oligodendrocyte progenitor cell differentiation.
Asubio Pharma
Discovery and structure-activity relationship of imidazolinylindole derivatives as kallikrein 7 inhibitors.
Asubio Pharma
Structure-based drug design of 1,3,6-trisubstituted 1,4-diazepan-7-ones as selective human kallikrein 7 inhibitors.
Asubio Pharma
Structure-based design, synthesis, and binding mode analysis of novel and potent chymase inhibitors.
Asubio Pharma
Discovery and structure-activity relationship study of 1,3,6-trisubstituted 1,4-diazepane-7-ones as novel human kallikrein 7 inhibitors.
Asubio Pharma
Structure-based drug design to overcome species differences in kallikrein 7 inhibition of 1,3,6-trisubstituted 1,4-diazepan-7-ones.
Asubio Pharma
